Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Immunovia’s Virtual Investor Day, Tuesday, June 30, 2020

June 30, 2020

The online event features presentations by Immunovia’s Chairman, Carl Borrebaeck; CEO, Mats Grahn; Chief Commercial Officer, Laura Chirica; Senior VP Sales North America, Michael Pettigrew; and Dr Thomas King, Medical Director, followed by a Q&A session.

Immunovia Presentation  – PDF version

0:00 Agenda Virtual Investor Day
3:24 Welcome & Introduction with Carl Borrebaeck
8:46 Company highlights and milestones with Mats Grahn and Carl Borrebaeck
12:50 The IMMray™ Platform and Market overview with Mats Grahn
22:08 Road to Market – Our Strategy with Laura Chirica
47:40 Building Sales organization in the US with Michael Pettigrew
1:05:25 Road to Market from Clinical perspectives with Thomas King
1:08:20 Virtual Lab tour, Marlborough MA, USA with Thomas King
1:12:14 Conclusion with Mats Grahn
1:13:09 Q&A Session